LIFLX
Price
$13.54
Change
-$0.41 (-2.94%)
Updated
Dec 18 closing price
RMFCX
Price
$54.22
Change
-$1.42 (-2.55%)
Updated
Dec 18 closing price
Ad is loading...

LIFLX vs RMFCX

Header iconLIFLX vs RMFCX Comparison
Open Charts LIFLX vs RMFCXBanner chart's image
Lord Abbett Focused Large Cap Value I
Price$13.54
Change-$0.41 (-2.94%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$54.22
Change-$1.42 (-2.55%)
VolumeN/A
CapitalizationN/A
LIFLX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
LIFLX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIFLX is a Buy and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 98.7B vs. LIFLX (32.2M). RMFCX pays higher dividends than LIFLX: RMFCX (1.69) vs LIFLX (0.00). LIFLX was incepted earlier than RMFCX: LIFLX (5 years) vs RMFCX (23 years). LIFLX is a more actively managed with annual turnover of: 61.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than LIFLX: RMFCX (250) vs LIFLX (1000000). LIFLX annual gain was more profitable for investors over the last year : 23.60 vs. RMFCX (12.63). RMFCX return over 5 years is better than : 40.39 vs. LIFLX (-8.15).
LIFLXRMFCXLIFLX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years23 years-
Gain YTD22.41911.423196%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets32.2M98.7B0%
Annual Yield % from dividends0.001.69-
Returns for 1 year23.6012.63187%
Returns for 3 years-5.1514.16-36%
Returns for 5 years-8.1540.39-20%
Returns for 10 yearsN/A61.84-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc